Samuel Funt

Trials

Studies that name Samuel Funt as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 17:20 UTC. Open this list on ClinicalTrials.gov

• N/A
  NCT07390617 · A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma

  Memorial Sloan Kettering Cancer Center · recruiting · Neuropathy, Urothelial Carcinoma, Metastatic Urothelial Carcinoma · principal investigator
• Ph2
  NCT03430895 · Evaluating Immune Therapy, Durvalumab (MEDI4736) With Tremelimumab for Metastatic, Non-transitional Cell Carcinoma of the Urinary Tract

  Memorial Sloan Kettering Cancer Center · completed · Non-Transitional Cell Carcinoma of the Urothelial Tract, Small Cell of the Bladder, Adenocarcinoma of the Bladder · principal investigator
• Ph2
  NCT03158064 · Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors

  Memorial Sloan Kettering Cancer Center · active not recruiting · Germ Cell Tumor, Nonseminomatous Germ Cell Tumor, Seminoma · principal investigator
• Ph2
  NCT03093922 · A Study of Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder Cancer

  Memorial Sloan Kettering Cancer Center · completed · Urothelial Carcinoma, Locally Advanced, Unresectable · principal investigator
• Ph1/Ph2
  NCT02989584 · A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer

  Memorial Sloan Kettering Cancer Center · active not recruiting · Bladder Cancer, Metastatic Bladder Cancer, Urothelial Carcinoma · principal investigator
• Ph2
  NCT02553642 · Relationship Between Tumor Mutation Burden and Predicted Neo-antigen Burden in Patients With Advanced Melanoma or Bladder Cancer Treated With Nivolumab or Nivolumab Plus Ipilimumab (CA209-260)

  Memorial Sloan Kettering Cancer Center · completed · Bladder Cancer, Melanoma · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-11 17:20 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.